文献速递神经肿瘤

前列腺特异性膜抗原(PSMA)通过89Zr-Df-IAB2M抗PSMA微抗体PET显像检测脑肿瘤新生血管的潜在应用

Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody.
PubMed 文献 · J Neurooncol · 2018-03-09

研究分析83例脑肿瘤或放射性坏死组织标本的PSMA免疫组化表达,并对3例复发高级别胶质瘤或转移性脑肿瘤患者行89Zr-Df-IAB2M PET显像。PSMA在高级别胶质瘤和转移性脑肿瘤血管内皮高表达,在原发性中枢神经系统淋巴瘤和放射性坏死低表达;PET可清晰显示高级别胶质瘤和转移瘤的PSMA表达,且摄取值与表达水平呈正相关趋势。

要点

  • PSMA在高级别胶质瘤和转移性脑肿瘤血管内皮高表达,在原发性中枢神经系统淋巴瘤和放射性坏死低表达。
  • 89Zr-Df-IAB2M PET可清晰显示高级别胶质瘤和转移性脑肿瘤的PSMA表达。
  • 89Zr-Df-IAB2M摄取值与肿瘤标本PSMA表达水平呈正相关趋势。

核心结论

  • 89Zr-Df-IAB2M PET显像PSMA可能在鉴别高级别胶质瘤与原发性中枢神经系统淋巴瘤或放射性坏死、预测疗效及评估贝伐珠单抗治疗反应方面具有潜在价值。

研究设计与样本

  • 对83例包含胶质瘤、转移性脑肿瘤、原发性中枢神经系统淋巴瘤或放射性坏死的组织标本行PSMA抗体免疫组化染色分析。
  • 对3例复发高级别胶质瘤或转移性脑肿瘤患者行89Zr-Df-IAB2M PET显像。

主要发现

  • PSMA在高级别胶质瘤和转移性脑肿瘤的血管内皮高表达,而在原发性中枢神经系统淋巴瘤和放射性坏死的血管内皮低表达。
  • 高级别胶质瘤和转移性脑肿瘤的PSMA表达在89Zr-Df-IAB2M PET显像中清晰可见。
  • 观察到89Zr-Df-IAB2M摄取值与肿瘤标本PSMA表达水平呈正相关趋势。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tumor angiogenesis has attracted increasing attention because of its potential as a valuable marker in the differential diagnosis of brain tumors as well as a novel therapeutic target. Prostate-specific membrane antigen (PSMA) is expressed by the neovasculature endothelium of some tumors, with little to no expression by the tumor cells or normal vasculature endothelium. The aim of this study was to investigate the potential of PSMA for the evaluation of the tumor neovasculature of various brain tumors and the possibility of detecting PSMA expression in brain tumors using PET imaging with 89Zr-Df-IAB2M (anti-PSMA minibody). Eighty-three tissue specimens including gliomas, metastatic brain tumors, primary central nervous system lymphomas (PCNSL), or radiation necroses were analyzed by immunohistochemical staining with PSMA antibody. 89Zr-Df-IAB2M PET scans were performed in three patients with recurrent high-grade gliomas or metastatic brain tumor. PSMA was highly expressed in the vascular endothelium of high-grade glioma and metastatic brain tumor, whereas PSMA was poorly expressed in the vascular endothelium of PCNSL and radiation necrosis. PSMA expression in high-grade gliomas and a metastatic brain tumor was clearly visualized by PET imaging with 89Zr-Df-IAB2M. Furthermore, a trend toward a positive correlation between the degree of 89Zr-Df-IAB2M uptake and PSMA expression levels in tumor specimens was observed. PET imaging of PSMA using 89Zr-Df-IAB2M may have potential value in the differential diagnosis of high-grade glioma from PCNSL or radiation necrosis as well as in the prediction of treatment efficacy and assessment of treatment response to bevacizumab therapy for high-grade glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Matsuda M, Ishikawa E, Yamamoto T, et al. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody. J Neurooncol. 2018. PMID: 29524126. doi:10.1007/s11060-018-2825-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。